Establishing a state-wide pelvic exenteration multidisciplinary team meeting in South Australia.
colorectal cancer
multidisciplinary care
pelvic exenteration
Journal
ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
revised:
04
12
2022
received:
14
11
2022
accepted:
13
12
2022
medline:
26
5
2023
pubmed:
27
12
2022
entrez:
26
12
2022
Statut:
ppublish
Résumé
Pelvic exenteration surgery is complex, necessitating co-ordinated multidisciplinary input and improved referral pathways. A state-wide pelvic exenteration multidisciplinary team (MDT) meeting was established in SA and the outcomes of this were audited and compared with historical data. All patients referred for discussion between August 2021 and July 2022 to the SA State-wide Pelvic Exenteration MDT were included in this study. MDT discussion centred around disease resectability, risk versus benefit of surgery, and need for local or interstate referral. Prospective data collection included patient demographics and MDT recommendations of surgery, palliation, or referral. Patients referred for surgery locally or interstate were compared with a retrospective patient cohort treated previously between January and December 2020. Over 12 months, 91 patients were discussed (including nine multiple times), by a mean of 18 meeting participants each month. Forty-eight patients (58.5%) had primary malignancy, 25 (30.5%) recurrent malignancy, and 9 (11.0%) had non-malignant disease. Colorectal cancer was the most common presentation (56.1%), followed by gynaecological (30.5%) and urological (6.1%) malignancy. Pelvic exenteration surgery was recommended to be performed locally in 53.7% of patients and the remainder for non-surgical treatment, palliation, or re-discussion. During this time, 44 patients underwent surgery locally (versus 34 in 2020) and only 4 referred interstate (versus 8 in 2020). The establishment of a dedicated state-wide pelvic exenteration MDT has resulted in better coordination of care for patients with locally advanced pelvic malignancy in SA, and significantly reduced the need for interstate referral.
Sections du résumé
BACKGROUND
Pelvic exenteration surgery is complex, necessitating co-ordinated multidisciplinary input and improved referral pathways. A state-wide pelvic exenteration multidisciplinary team (MDT) meeting was established in SA and the outcomes of this were audited and compared with historical data.
METHODS
All patients referred for discussion between August 2021 and July 2022 to the SA State-wide Pelvic Exenteration MDT were included in this study. MDT discussion centred around disease resectability, risk versus benefit of surgery, and need for local or interstate referral. Prospective data collection included patient demographics and MDT recommendations of surgery, palliation, or referral. Patients referred for surgery locally or interstate were compared with a retrospective patient cohort treated previously between January and December 2020.
RESULTS
Over 12 months, 91 patients were discussed (including nine multiple times), by a mean of 18 meeting participants each month. Forty-eight patients (58.5%) had primary malignancy, 25 (30.5%) recurrent malignancy, and 9 (11.0%) had non-malignant disease. Colorectal cancer was the most common presentation (56.1%), followed by gynaecological (30.5%) and urological (6.1%) malignancy. Pelvic exenteration surgery was recommended to be performed locally in 53.7% of patients and the remainder for non-surgical treatment, palliation, or re-discussion. During this time, 44 patients underwent surgery locally (versus 34 in 2020) and only 4 referred interstate (versus 8 in 2020).
CONCLUSION
The establishment of a dedicated state-wide pelvic exenteration MDT has resulted in better coordination of care for patients with locally advanced pelvic malignancy in SA, and significantly reduced the need for interstate referral.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1227-1231Informations de copyright
© 2022 The Authors. ANZ Journal of Surgery published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Surgeons.
Références
Humphries EL, Kroon HM, Dudi-Venkata NN, Thomas ML, Moore JW, Sammour T. Short- and long-term outcomes of selective pelvic exenteration surgery in a low-volume specialized tertiary setting. ANZ J. Surg. 2019; 89: E226-30.
Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br. J. Surg. 2013; 100: E1-E33.
Vallance AE, Harji D, Fearnhead NS, IMPACT Collaborative. Making an IMPACT: a priority setting consultation exercise to improve outcomes in patients with locally advanced, recurrent and metastatic colorectal cancer. Eur. J. Surg. Oncol. 2019; 45: 1567-74.
PelvEx Collaborative. Perioperative management and anaesthetic considerations in pelvic exenterations using Delphi methodology: results from the PelvEx collaborative. BJS Open 2021; 5: zraa055.
Newman EA, Guest AB, Helvie MA et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer 2006; 107: 2346-51.
Kontovounisios C, Tekkis P. Locally advanced disease and pelvic exenterations. Clin. Colon Rectal Surg. 2017; 30: 404-14.
Junor EJ, Hole DJ, Gillis CR. Management of ovarian cancer: referral to a multidisciplinary team matters. Br. J. Cancer 1994; 70: 363-70.
O'Shannassy SJ, Brown KGM, Steffens D, Solomon MJ. Referral patterns and outcomes of a highly specialised pelvic exenteration multidisciplinary team meeting: a retrospective cohort study. Eur. J. Surg. Oncol. 2020; 46: 1138-43.
Hung HC, Hsu PJ, Chang TC et al. The impact of multidisciplinary team approach on cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. J. Pers. Med. 2021; 11: 1313-26.
Jurado M, Chiva L, Tinelli G, Alcazar JL, Chi DS. The role of oncovascular surgery in gynecologic oncology surgery. Int. J. Gynecol. Cancer 2022; 32: 553-9.
Falzone L, Scandurra G, Lombardo V et al. A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (review). Int. J. Oncol. 2021; 59: 53-66.
Blake J, Koh CE, Steffens D et al. Outcomes following repeat exenteration for locally advanced pelvic malignancy. Colorectal Dis. 2021; 23: 646-52.
PelvEx Collaborative. Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration. Ann. Surg. 2019; 269: 315-21.
Matsuo K, Matsuzaki S, Mandelbaum RS et al. Hospital surgical volume and perioperative mortality of pelvic exenteration for gynecologic malignancies. J. Surg. Oncol. 2020; 121: 402-9.
PelvEx Collaborative. Contemporary management of locally advanced and recurrent rectal cancer: views from the PelvEx collaborative. Cancers (Basel). 2022; 14: 1161-79.
Dinger TL, Kroon HM, Traeger L, Bedrikovetski S, Hunter A, Sammour T. Regional variance in treatment and outcomes of locally invasive (T4) rectal cancer in Australia and New Zealand: analysis of the Bi-National Colorectal Cancer Audit. ANZ J. Surg. 2022; 92: 1772-80.
Traeger L, Bedrikovetski S, Oehler MK et al. Short-term outcomes following development of a dedicated pelvic exenteration service in a tertiary Centre. ANZ J. Surg. 2022; 92: 2620-7.
Sooriakumaran P, Dick JA, Thompson AC, Morley R. The central urology multidisciplinary team - is it time to change the referral criteria? An audit of practice in a district general hospital in London. Ann. R. Coll. Surg. Engl. 2009; 91: 700-2.
Gould LE, Pring ET, Drami I et al. A systematic review of the pathological determinants of outcome following resection by pelvic exenteration of locally advanced and locally recurrent rectal cancer. Int. J. Surg. 2022; 104: 106738.
Hagemans JAW, van Rees JM, Alberda WJ et al. Locally recurrent rectal cancer; long-term outcome of curative surgical and non-surgical treatment of 447 consecutive patients in a tertiary referral centre. Eur. J. Surg. Oncol. 2020; 46: 448-54.
Stephens MR, Lewis WG, Brewster AE et al. Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer. Dis. Esophagus 2006; 19: 164-71.
Zucca A, Boyes A, Newling G, Hall A, Girgis A. Travelling all over the countryside: travel-related burden and financial difficulties reported by cancer patients in New South Wales and Victoria. Aust. J. Rural Health 2011; 19: 298-305.
Luijten J, Nieuwenhuijzen GAP, Sosef MN et al. Impact of nationwide centralization of oesophageal, gastric, and pancreatic surgery on travel distance and experienced burden in The Netherlands. Eur. J. Surg. Oncol. 2022; 48: 348-55.